BackgroundIfosfamide, an alkylating agent used to treat various malignancies, has limited real-world safety data on neurotoxicity. Therefore, this study analyzed ifosfamide-related Central Nervous System Adverse Events (CNS AEs) to provide a reference for drug risk management.MethodsThe disproportio...